Want to join the conversation?
Danilo Juvane of BMO Capital asks about the cost reductions $WMB is targeting for the rest of 2016 and for 2017. CEO Alan Armstrong says the company cut 12% of its headcount so far in 2016. He indicates that similar exercises would continue. "We're hopeful to continue to improve on the cost savings beyond what we have today as we get into 2017."
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?